Business
Third member of FDA advisory panel resigns over Alzheimer’s drug approval – NBC News
A third member of a panel of outside advisers to the U.S. Food and Drug Administration has resigned in protest over the agency’s…
A third member of a panel of outside advisers to the U.S. Food and Drug Administration has resigned in protest over the agency’s decision to approve Biogen Inc’s Alzheimer’s disease treatment despite the committee’s recommendation against doing so.
Aaron…
Continue Reading
-
Business16 hours agoWhy is Alphabet stock worth less than Nvidia, Microsoft, Apple, and Amazon even though it is the most profitable S&P 500 company?
-
General22 hours agoMichael Beatty, veteran current affairs journalist and animal welfare advocate, dies aged 76
-
Noosa News15 hours ago‘Sunny, benign’ school holiday weather after morning showers in parts of Queensland
-
Noosa News12 hours agoTips to improve engagement – Proctor